61 related articles for article (PubMed ID: 20675072)
1. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.
Crook J; Borg J; Evans A; Toi A; Saibishkumar EP; Fung S; Ma C
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1323-9. PubMed ID: 20675072
[TBL] [Abstract][Full Text] [Related]
2. Iodine-125 Brachytherapy for Palliative Treatment of Painful Colorectal Cancer Port-Site Metastases.
Liu X; Yu H; Zhao J; Di X; Wang J; Zhang H
J Gastrointest Cancer; 2024 Mar; 55(1):198-201. PubMed ID: 37889435
[TBL] [Abstract][Full Text] [Related]
3. Prostate-Specific Antigen Bounce after
Kim TH; Lee JJB; Cho J
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230829
[TBL] [Abstract][Full Text] [Related]
4. High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up.
Behmueller M; Tselis N; Zamboglou N; Zoga E; Baltas D; Rödel C; Chatzikonstantinou G
Front Oncol; 2021; 11():770959. PubMed ID: 34926278
[TBL] [Abstract][Full Text] [Related]
5. Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy.
Martell K; Roy S; Meyer T; Stosky J; Jiang W; Thind K; Roumeliotis M; Bosch J; Angyalfi S; Quon H; Husain S
Heliyon; 2020 Jun; 6(6):e04092. PubMed ID: 32548323
[TBL] [Abstract][Full Text] [Related]
6. A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate.
Fischer-Valuck BW; Gay HA; Patel S; Baumann BC; Michalski JM
Front Oncol; 2019; 9():1378. PubMed ID: 31921640
[TBL] [Abstract][Full Text] [Related]
7. Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification.
Matzkin H; Chen J; Agai R; Ziv-Baran T; Mabjeesh NJ
PLoS One; 2019; 14(4):e0215582. PubMed ID: 31002732
[TBL] [Abstract][Full Text] [Related]
8. Low dose rate prostate brachytherapy.
Stish BJ; Davis BJ; Mynderse LA; McLaren RH; Deufel CL; Choo R
Transl Androl Urol; 2018 Jun; 7(3):341-356. PubMed ID: 30050795
[TBL] [Abstract][Full Text] [Related]
9. COMP report: CPQR technical quality control guidelines for low-dose-rate permanent seed brachytherapy.
Beaulieu L; Radford DA; Eduardo Villarreal-Barajas J
J Appl Clin Med Phys; 2018 May; 19(3):13-18. PubMed ID: 29542269
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of 125I brachytherapy with and without external-beam radiation therapy for localized prostate cancer: results from 300 patients at a single institution in Japan.
Maki S; Itoh Y; Kubota S; Okada T; Nakahara R; Ito J; Kawamura M; Naganawa S; Yoshino Y; Fujita T; Kato M; Gotoh M; Ikeda M
J Radiat Res; 2017 Nov; 58(6):870-880. PubMed ID: 28992050
[TBL] [Abstract][Full Text] [Related]
11. Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product.
Rose J; Liu D; Boychak O; Sloboda R; Pervez N; Murtha A; Yee D; Amanie J; Usmani N
Cureus; 2017 May; 9(5):e1243. PubMed ID: 28620572
[TBL] [Abstract][Full Text] [Related]
12. Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy.
Makino T; Miwa S; Koshida K
Prostate Int; 2016 Dec; 4(4):152-155. PubMed ID: 27995115
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent
Kovalainen E; Vaarala MH
Mol Clin Oncol; 2016 Nov; 5(5):647-650. PubMed ID: 27900104
[TBL] [Abstract][Full Text] [Related]
14. Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions.
Fellin G; Mirri MA; Santoro L; Jereczek-Fossa BA; Divan C; Mussari S; Ziglio F; La Face B; Barbera F; Buglione M; Bandera L; Ghedi B; Di Muzio NG; Losa A; Mangili P; Nava L; Chiarlone R; Ciscognetti N; Gastaldi E; Cattani F; Spoto R; Vavassori A; Giglioli FR; Guarneri A; Cerboneschi V; Mignogna M; Paoluzzi M; Ravaglia V; Chiumento C; Clemente S; Fusco V; Santini R; Stefanacci M; Mangiacotti FP; Martini M; Palloni T; Schinaia G; Lazzari G; Silvano G; Magrini S; Ricardi U; Santoni R; Orecchia R
Br J Radiol; 2016 Sep; 89(1065):20150981. PubMed ID: 27384381
[TBL] [Abstract][Full Text] [Related]
15. Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.
Fernandez Ots A; Bucci J; Chin YS; Malouf D; Howie A; Enari KE
JMIR Res Protoc; 2016 Jun; 5(2):e98. PubMed ID: 27296781
[TBL] [Abstract][Full Text] [Related]
16. Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer.
Guinot JL; Ricós JV; Tortajada MI; Santos MA; Casanova J; Clemente J; Samper J; Santamaría P; Arribas L
J Contemp Brachytherapy; 2015 Aug; 7(4):258-64. PubMed ID: 26622228
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy.
Wang Y; Nasser NJ; Borg J; Saibishkumar EP
J Contemp Brachytherapy; 2015 Jun; 7(3):203-10. PubMed ID: 26207108
[TBL] [Abstract][Full Text] [Related]
18. In vivo visualization of prostate brachytherapy seeds with photoacoustic imaging.
Lediju Bell MA; Kuo NP; Song DY; Kang JU; Boctor EM
J Biomed Opt; 2014 Dec; 19(12):126011. PubMed ID: 25531797
[TBL] [Abstract][Full Text] [Related]
19. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
Pugh TJ; Mahmood U; Swanson DA; Munsell MF; Wang R; Kudchadker RJ; Bruno TL; Frank SJ
Brachytherapy; 2015; 14(2):160-5. PubMed ID: 25255712
[TBL] [Abstract][Full Text] [Related]
20. Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.
Arscott WT; Chen LN; Wilson N; Bhagat A; Kim JS; Moures RA; Yung TM; Lei S; Collins BT; Kowalczyk K; Suy S; Dritschilo A; Lynch JH; Collins SP
Radiat Oncol; 2014 Jul; 9():163. PubMed ID: 25056726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
